Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants

Research Focus: The study investigated the potential of cannabinoids from hemp (Cannabis sativa) as therapeutic agents against SARS-CoV-2, including its emerging variants. Key Findings: Conclusion: This study presents evidence that cannabinoids like CBDA and CBGA can effectively block the cellular entry of SARS-CoV-2 and its emerging variants. These findings open up possibilities for new therapeutic strategies against COVID-19, particularly in managing infections by different variants of the virus. Read More: